PUBLICATIONS
PRESS RELEASES
The Next Big Thing In Drug Development May Be The Ubiquitin Pathway
Date: April 1, 2010
Pharmaceutical Approvals Monthly -- Velcade, Millennium's successful first-in-class cancer therapy, is held up as a poster drug for manipulating the ubiquitin system to attack disease. Yet it taps only the most rudimentary process of an elegant and little understood cellular mechanism that some are betting will be the next big source of innovation in drug development.
Download PDF
Prelude To a Kiss of Death
Date: November 16, 2009
Targeting early steps in protein disposal could lead to drugs for cancer and more. Read article to find out more.
Visit Site
VLI Research Presents Molecular Medicine and Ubiquitin Meeting in Philadelphia, USA
Date: August 13, 2009
Download PDF
